Preoperative erlotinib in clinical stage I and II non-small cell lung cancer.

被引：0
|
作者：
Port, J. L. [1 ]
Yankelevitz, D. [1 ]
Lee, P. C. [1 ]
Spinelli, C. [1 ]
Altorki, N. K. [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13639
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk Factors for the Recurrence in Patients with Stage I and II Non-Small Cell Lung Cancer.
    Park, I. W.
    Cho, S. G.
    Kang, H. G.
    Lee, H. M.
    Kwak, H. W.
    Chung, J. W.
    Choi, J. C.
    Shin, J. W.
    Kim, J. Y.
    Choi, B. W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [2] Therapy for stage I and stage II non-small cell lung cancer
    Tanoue, LT
    Ponn, RB
    [J]. CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 173 - +
  • [3] Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.
    Komaki, R.
    Blumenschein, G. R.
    Wistuba, I. I.
    Lee, J. J.
    Allen, P.
    Wei, X.
    Welsh, J.
    O'Reilly, M.
    Herbst, R. S.
    Tang, X.
    Meyn, R.
    Liu, D.
    Hong, W. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Resection in Stage I/II Non-Small Cell Lung Cancer
    Smolle-Juettner, F. M.
    Maier, A.
    Lindenmann, J.
    Matzi, V.
    Neuboeck, N.
    [J]. CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 71 - 77
  • [5] A PHASE I / II TRIAL OF THE HDAC INHIBITOR BELINOSTAT IN COMBINATION WITH ERLOTINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER.
    Andersen, Jon L.
    Holm, Bente
    Rasmussen, Trine S.
    Mellemgaard, Anders
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1201 - S1202
  • [6] Radiotherapy for medically inoperable non-small cell lung cancer at clinical stage I and II
    Yamada, K
    Soejima, T
    Ota, Y
    Sasaki, R
    Yoden, E
    Kanaoka, N
    Maruta, T
    Sugimura, K
    [J]. TUMORI, 2003, 89 (01) : 75 - 79
  • [7] A Phase I/II Study Combining Erlotinib andDasatinib for Non-Small Cell Lung Cancer
    Gold, Kathryn A.
    Lee, J. Jack
    Harun, Nusrat
    Tang, Ximing
    Price, Justina
    Kawedia, Jitesh D.
    Tran, Hai T.
    Erasmus, Jeremy J.
    Blumenschein, George R.
    William, Awilliam N.
    Wistuba, Ignacio I.
    Johnson, Faye M.
    [J]. ONCOLOGIST, 2014, 19 (10): : 1040 - 1041
  • [8] Hypofractionated Radiotherapy for Stage I and II Non-Small Cell Lung Cancer
    Kuremsky, J. G.
    Petty, W. J.
    Miller, A.
    Hinson, W. H.
    Hampton, C. J.
    Blackstock, A. W.
    Urbanic, J. J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S230 - S230
  • [9] Chemotherapy in stage I+II non-small cell lung cancer
    Ukena, D
    [J]. LUNG CANCER, 2001, 33 : S25 - S28
  • [10] Adjuvant therapy for stage I and II non-small cell lung cancer
    Dorr, VJ
    Perry, MC
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (02) : 267 - +
12345